Matches in Wikidata for { <http://www.wikidata.org/entity/Q63884023> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q63884023 description "im September 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q63884023 description "wetenschappelijk artikel" @default.
- Q63884023 description "наукова стаття, опублікована у вересні 2017" @default.
- Q63884023 name "155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial" @default.
- Q63884023 name "155PDTumor-infiltrating lymphocytes" @default.
- Q63884023 type Item @default.
- Q63884023 label "155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial" @default.
- Q63884023 label "155PDTumor-infiltrating lymphocytes" @default.
- Q63884023 prefLabel "155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial" @default.
- Q63884023 prefLabel "155PDTumor-infiltrating lymphocytes" @default.
- Q63884023 P1433 Q63884023-A27F49CC-5B11-4671-9386-16FAE62D9663 @default.
- Q63884023 P1476 Q63884023-A17D4141-849B-4AE0-A6FC-0B852BAB7B87 @default.
- Q63884023 P2093 Q63884023-00E0583A-4A37-4FD7-A194-28A77ADFA682 @default.
- Q63884023 P2093 Q63884023-21A772C7-6363-4E04-A616-4F574C693796 @default.
- Q63884023 P2093 Q63884023-4FD5B99E-C0C9-47F3-A1CF-A4EAA5521D38 @default.
- Q63884023 P2093 Q63884023-53D64512-3373-432A-89D8-27266A35914B @default.
- Q63884023 P2093 Q63884023-5E6B4316-FF7D-4A4F-A00F-4D3D76E12DB9 @default.
- Q63884023 P2093 Q63884023-660F71F8-52A0-43F1-9EAF-F28CC1ECA6D5 @default.
- Q63884023 P2093 Q63884023-6F888064-6862-4994-825B-97B54709CFD2 @default.
- Q63884023 P2093 Q63884023-882D574D-36BD-4011-A6FD-A40D84800CA5 @default.
- Q63884023 P2093 Q63884023-91240E4B-1C2D-42CA-9037-066BF336035E @default.
- Q63884023 P2093 Q63884023-912764BA-3D58-4938-BB79-378C6B8A42A4 @default.
- Q63884023 P2093 Q63884023-91BC83FC-616C-41C6-B3B6-473BD1B27162 @default.
- Q63884023 P2093 Q63884023-934B9466-F14C-4E40-B3A6-BABF8BF99BCF @default.
- Q63884023 P2093 Q63884023-A751296E-1251-47D5-B1DC-35DB95510D50 @default.
- Q63884023 P2093 Q63884023-B995DDC8-8A12-402D-BCF1-A026CE222B23 @default.
- Q63884023 P2093 Q63884023-CFC2B327-CB3E-4ABA-B53A-840FDB0C6A74 @default.
- Q63884023 P2093 Q63884023-E5871563-DB4C-4726-A9D9-DD475AF999A5 @default.
- Q63884023 P2093 Q63884023-E6CC4D49-9A23-44B2-B9E7-CDE8855E1A93 @default.
- Q63884023 P2093 Q63884023-ECE9EC0F-8EB5-4BC0-9118-FE2F64CAB2ED @default.
- Q63884023 P2093 Q63884023-FF812B52-A08E-43BE-ABAE-A43C38AA25C1 @default.
- Q63884023 P31 Q63884023-013429EC-C330-4B80-AE17-7BE0EDC0C5E6 @default.
- Q63884023 P356 Q63884023-7B9D8C6F-16DB-4C81-BA72-1CC998C6BC9D @default.
- Q63884023 P433 Q63884023-860FFFF3-E7AD-44A7-83CA-EED943575FE8 @default.
- Q63884023 P478 Q63884023-EE28B755-9BBD-4735-A419-BAECDF064F6E @default.
- Q63884023 P50 Q63884023-323367E3-2847-428A-BB7F-326578D77A0D @default.
- Q63884023 P577 Q63884023-D8E8DCB2-6E33-4B26-889F-7DB157580ED0 @default.
- Q63884023 P921 Q63884023-A95FCA3B-7102-40CF-B6DE-245B604737EB @default.
- Q63884023 P921 Q63884023-E5B7AF05-9248-45C0-B57A-38F3059FD531 @default.
- Q63884023 P356 MDX362.006 @default.
- Q63884023 P1433 Q326122 @default.
- Q63884023 P1476 "155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial" @default.
- Q63884023 P2093 "A. Llombart" @default.
- Q63884023 P2093 "A. Prat" @default.
- Q63884023 P2093 "B. Bermejo De Las Heras" @default.
- Q63884023 P2093 "E. Holgado" @default.
- Q63884023 P2093 "E. Martinez de Dueñas" @default.
- Q63884023 P2093 "I. Garau" @default.
- Q63884023 P2093 "J. Alarcon Company" @default.
- Q63884023 P2093 "J. Cortes Castan" @default.
- Q63884023 P2093 "L. Manso" @default.
- Q63884023 P2093 "L. Paré" @default.
- Q63884023 P2093 "M. Muñoz" @default.
- Q63884023 P2093 "M. Oliveira" @default.
- Q63884023 P2093 "M. Vidal" @default.
- Q63884023 P2093 "N. Martínez Jañez" @default.
- Q63884023 P2093 "P. Villagrasa Gonzalez" @default.
- Q63884023 P2093 "R. Fasani" @default.
- Q63884023 P2093 "R. López" @default.
- Q63884023 P2093 "S. Pernas Simon" @default.
- Q63884023 P2093 "T. Pascual" @default.
- Q63884023 P31 Q13442814 @default.
- Q63884023 P356 "10.1093/ANNONC/MDX362.006" @default.
- Q63884023 P433 "suppl_5" @default.
- Q63884023 P478 "28" @default.
- Q63884023 P50 Q37386010 @default.
- Q63884023 P577 "2017-09-01T00:00:00Z" @default.
- Q63884023 P921 Q412616 @default.
- Q63884023 P921 Q974135 @default.